< -5%

-5% to -3%

Autoline Ind

-3% to 0%

Jay BharatMarut

Omax Autos

0% to 3%

Rasandik Engg

3% to 5%

The shares of <a href="https://www.moneycontrol.com/india/stockpricequote/hospitalhealthcare-services/parkmediworld/PMWL">Park Medi World</a> made a weak market debut on December 16, listing at Rs 155.60 apiece on BSE. This marks a discount of 3.95 percent over the IPO price of Rs 162 per share. The company's market capitalisation during debut stood at Rs 6,720.84 crore.

On NSE, the shares listed with a slightly lower discount of 1.98 percent at Rs 158.80 apiece.

This comes after the Rs 920-crore initial public offering of the company that operates hospital chain under the brand Park Hospital saw <a href="https://www.moneycontrol.com/news/business/ipo/park-medi-world-ipo-gets-fully-subscribed-on-day-3-gmp-suggests-tepid-listing-13722599.html">strong investor interest</a> during its three days of public bidding, being subscribed more than 8 times its offer size between December 10 and December 12.
<h3><strong>Listing performance vs grey market expectations:</strong></h3>
The listing performance has significantly misses grey market estimates. Ahead of listing, the unlisted shares of the company were trading with 3.09 percent grey market premium (GMP) over the IPO price, according to data on Investorgain. The GMP has fallen from the 20.40 percent quoted by the site on December 7.

According to IPO Watch, the unlisted shares of the company were trading with 3.09 percent GMP over the issue price.
<h3><strong>About Park Medi World IPO:</strong></h3>
Park Medi World launched its IPO to raise Rs 920 crore through a fresh issue of 4.75 crore shares worth Rs 770 crore and an offer for sale (OFS) of shares worth Rs 150 crore by promoter Ajit Gupta. The IPO had a price band of Rs 154-162 per shares.

Investors could bid for a minimum of 92 shares, requiring an investment of Rs 14,904 at the upper price band, and in multiples thereafter.
<h3><strong>How will the IPO proceeds be used?</strong></h3>
Park Medi World, that operates the second largest private hospital chain in North India with 3,000 beds capacity, will utilise Rs 380 crore of fresh issue proceeds for repayment of certain outstanding borrowings.

The company will use Rs 60.5 crore for development of new hospital by subsidiary Park Medicity (NCR), Rs 27.4 crore for purchase of medical equipment, and the remainder funds for unidentified inorganic acquisitions and general corporate purposes.

Nuvama Wealth Management, CLSA India, DAM Capital Advisors, and Intensive Fiscal Services are managing the Park Hospital IPO.
<h3><strong>What lies ahead?</strong></h3>
Park Medi World Limited is the second-largest private hospital chain in North India with 3,000 beds, and the largest in Haryana with 1,600 beds as of March 31, 2025, noted Anand Rathi. Their network comprises 14 NABH-accredited multi-super specialty hospitals under the 'Park' brand, including eight that are also NABL accredited, it added.

"A key element of their strategy is to attract and retain qualified and experienced doctors, consultants, and medical professionals to maintain and enhance the quality of care they provide," the domestic brokerage said, adding that the IPO appears fairly valued. It advised investors to subscribe to the issue for the long term.

Follow all <a href="https://www.moneycontrol.com/ipo/">IPO news</a> here.

<em>Disclaimer: The views and investment tips expressed by experts on Moneycontrol are their own and not those of the website or its management. Moneycontrol advises users to check with certified experts before taking any investment decisions.</em>

Ownership, Material Conflicts of Interest and Disciplinary History

MCD is a wholly owned subsidiary of Network 18 Media & Investments Ltd ("Network18"), in which Independent Media Trust (IMT) holds 56.89% stake. Reliance Industries Limited ("RIL") is the sole beneficiary of IMT. Network18 and RIL and their subsidiaries, joint ventures and associates can be considered as associates of MCD.

Details of Associate

Receipt of Compensation

Third-Party Compensation

Employment History

Market-Making Activities

Use of Artificial Intelligence

Park Medi World shares make weak market debut, list at 4% discount to IPO price on BSE

The shares of Park Medi World made a weak market debut on December 16, listing at Rs 155.60 apiece on BSE. This marks a discount of 3.95 percent over the IPO price of Rs 162 per share. The company's market capitalisation during debut stood at Rs 6,720.84 crore.

On NSE, the shares listed with a slightly lower discount of 1.98 percent at Rs 158.80 apiece.

This comes after the Rs 920-crore initial public offering of the company that operates hospital chain under the brand Park Hospital saw strong investor interest during its three days of public bidding, being subscribed more than 8 times its offer size between December 10 and December 12.
Listing performance vs grey market expectations:
The listing performance has significantly misses grey market estimates. Ahead of listing, the unlisted shares of the company were trading with 3.09 percent grey market premium (GMP) over the IPO price, according to data on Investorgain. The GMP has fallen from the 20.40 percent quoted by the site on December 7.

According to IPO Watch, the unlisted shares of the company were trading with 3.09 percent GMP over the issue price.
About Park Medi World IPO:
Park Medi World launched its IPO to raise Rs 920 crore through a fresh issue of 4.75 crore shares worth Rs 770 crore and an offer for sale (OFS) of shares worth Rs 150 crore by promoter Ajit Gupta. The IPO had a price band of Rs 154-162 per shares.

Investors could bid for a minimum of 92 shares, requiring an investment of Rs 14,904 at the upper price band, and in multiples thereafter.
How will the IPO proceeds be used?
Park Medi World, that operates the second largest private hospital chain in North India with 3,000 beds capacity, will utilise Rs 380 crore of fresh issue proceeds for repayment of certain outstanding borrowings.

The company will use Rs 60.5 crore for development of new hospital by subsidiary Park Medicity (NCR), Rs 27.4 crore for purchase of medical equipment, and the remainder funds for unidentified inorganic acquisitions and general corporate purposes.

Nuvama Wealth Management, CLSA India, DAM Capital Advisors, and Intensive Fiscal Services are managing the Park Hospital IPO.
What lies ahead?
Park Medi World Limited is the second-largest private hospital chain in North India with 3,000 beds, and the largest in Haryana with 1,600 beds as of March 31, 2025, noted Anand Rathi. Their network comprises 14 NABH-accredited multi-super specialty hospitals under the 'Park' brand, including eight that are also NABL accredited, it added.

&quot;A key element of their strategy is to attract and retain qualified and experienced doctors, consultants, and medical professionals to maintain and enhance the quality of care they provide,&quot; the domestic brokerage said, adding that the IPO appears fairly valued. It advised investors to subscribe to the issue for the long term.

Follow all IPO news here.

Disclaimer: The views and investment tips expressed by experts on Moneycontrol are their own and not those of the website or its management. Moneycontrol advises users to check with certified experts before taking any investment decisions.

The shares of <a href="https://www.moneycontrol.com/india/stockpricequote/hospitalhealthcare-services/nephrocarehealthservices/NHSL">Nephrocare Health Services</a> made a tepid market debut on December 17, listing at Rs 490 apiece on NSE. This marks a premium of 6.52 percent over the IPO price of Rs 460 per share.

On BSE, the shares listed with 6.89 percent premium over the IPO price. The company debuted with a market capitalization of Rs 4,934 crore.

This comes after the Rs 871-crore initial public offering of Asia's largest dialysis service provider under the Nephroplus brand saw <a href="https://www.moneycontrol.com/news/business/ipo/nephrocare-health-services-ipo-subscribed-50-on-day-3-so-far-retail-portion-booked-64-check-latest-gmp-13722649.html">strong investor interest</a> during its three days of public bidding, being subscribed 14 times its offer size between December 10 and December 12.
<h3><strong>Listing premium vs grey market estimates:</strong></h3>
Ahead of listing, the unlisted shares of the company were trading with 8.04 percent grey market premium (GMP) over the IPO price, according to data on Investorgain. According to IPO Watch, the unlisted shares of the company were trading with 8.69 percent GMP over the IPO price.
<h3><strong>About Nephrocare Health Services IPO:</strong></h3>
Nephrocare Health Services launched its IPO to raise Rs 871 crore through a combination of fresh issue of shares worth Rs 353.4 crore and an offer for sale (OFS) of 1.12 crore shares by existing shareholders including promoters Investcorp, Healthcare Parent, Edoras Investment Holdings, International Finance Corporation, and 360 ONE.

The price band for the IPO was set at Rs 438-460 per share.
<h3><strong>What lies ahead?</strong></h3>
At the upper price band, the IPO values the company at P/E of 60.2x with EV/EBITDA of 26x to its FY25 earnings and market cap of Rs 461.53 crore post issue of equity shares, said Anand Rathi.

<a href="https://www.moneycontrol.com/news/business/trade/subscribe-for-nephrocare-health-services-ltd-ipo-geojit-financial-services-13721021.html">Geojit Financial Services</a> meanwhile said that the company aims to strengthen its presence by launching new clinics, partnering with hospitals for asset-light growth, and improving accessibility in underserved regions. It had advised investors to subscribe to the issue with a long-term horizon.

Follow all <a href="https://www.moneycontrol.com/ipo/">IPO news</a> here.

<em>Disclaimer: The views and investment tips expressed by experts on Moneycontrol are their own and not those of the website or its management. Moneycontrol advises users to check with certified experts before taking any investment decisions.</em>

Nephrocare Health Services shares list at 7% premium to IPO price

The shares of Nephrocare Health Services made a tepid market debut on December 17, listing at Rs 490 apiece on NSE. This marks a premium of 6.52 percent over the IPO price of Rs 460 per share.

On BSE, the shares listed with 6.89 percent premium over the IPO price. The company debuted with a market capitalization of Rs 4,934 crore.

This comes after the Rs 871-crore initial public offering of Asia's largest dialysis service provider under the Nephroplus brand saw strong investor interest during its three days of public bidding, being subscribed 14 times its offer size between December 10 and December 12.
Listing premium vs grey market estimates:
Ahead of listing, the unlisted shares of the company were trading with 8.04 percent grey market premium (GMP) over the IPO price, according to data on Investorgain. According to IPO Watch, the unlisted shares of the company were trading with 8.69 percent GMP over the IPO price.
About Nephrocare Health Services IPO:
Nephrocare Health Services launched its IPO to raise Rs 871 crore through a combination of fresh issue of shares worth Rs 353.4 crore and an offer for sale (OFS) of 1.12 crore shares by existing shareholders including promoters Investcorp, Healthcare Parent, Edoras Investment Holdings, International Finance Corporation, and 360 ONE.

The price band for the IPO was set at Rs 438-460 per share.
What lies ahead?
At the upper price band, the IPO values the company at P/E of 60.2x with EV/EBITDA of 26x to its FY25 earnings and market cap of Rs 461.53 crore post issue of equity shares, said Anand Rathi.

Geojit Financial Services meanwhile said that the company aims to strengthen its presence by launching new clinics, partnering with hospitals for asset-light growth, and improving accessibility in underserved regions. It had advised investors to subscribe to the issue with a long-term horizon.

Follow all IPO news here.

Disclaimer: The views and investment tips expressed by experts on Moneycontrol are their own and not those of the website or its management. Moneycontrol advises users to check with certified experts before taking any investment decisions.

<a href="https://www.moneycontrol.com/india/stockpricequote/constructioncontracting-civil/ahluwaliacontractsindia/ACI12">Ahluwalia Contracts</a> share price gained 5% percent in the opening trade on December 17 following the company won a civil construction contract of Rs 888.38 crore.

At 09:17 hrs Ahluwalia Contracts India was quoting at Rs 1,003.45, up Rs 49.00, or 5.13 percent, on the BSE.

Bihar State Tourism Development Corporation has awarded a contract to the company for construction and overall development work of Shri Ram Janmabhoomi Tirtha Kshetra, Ayodhya at Punauradham the birthplace of Mother Sita situated at Sitamarhi District (Bihar) on EPC mode, which is to be executed in 42 months.

<a href="https://www.moneycontrol.com/news/business/markets/stock-market-live-updates-gift-nifty-indicates-a-flat-opening-us-asian-markets-mixed-liveblog-13728846.html"><strong>Catch all the market action on our live blog</strong></a>

The company had reported 106 percent year-on-year (YoY) rise in its Q2FY26 net profit at Rs 79 crore against the Rs 38.36 crore net profit.

The firm’s revenue from operations rose over 16 percent YoY to Rs 1,177 crore

In the previous trading session, the share closed at Rs 954.45, down Rs 14.75, or 1.52 percent.

The share touched a 52-week high of Rs 1,134.95 and a 52-week low of Rs 620.65 on 02 January, 2025 and 18 February, 2025, respectively.

Currently, the stock is trading 15.9 percent below its 52-week high and 53.78 percent above its 52-week low.

The market capitalisation of the company stands at Rs 6,393.63 crore.

Ahluwalia Contracts shares gain 5% on order win worth Rs 888 crore

Ahluwalia Contracts share price gained 5% percent in the opening trade on December 17 following the company won a civil construction contract of Rs 888.38 crore.

At 09:17 hrs Ahluwalia Contracts India was quoting at Rs 1,003.45, up Rs 49.00, or 5.13 percent, on the BSE.

Bihar State Tourism Development Corporation has awarded a contract to the company for construction and overall development work of Shri Ram Janmabhoomi Tirtha Kshetra, Ayodhya at Punauradham the birthplace of Mother Sita situated at Sitamarhi District (Bihar) on EPC mode, which is to be executed in 42 months.

Catch all the market action on our live blog

The company had reported 106 percent year-on-year (YoY) rise in its Q2FY26 net profit at Rs 79 crore against the Rs 38.36 crore net profit.

The firm’s revenue from operations rose over 16 percent YoY to Rs 1,177 crore

In the previous trading session, the share closed at Rs 954.45, down Rs 14.75, or 1.52 percent.

The share touched a 52-week high of Rs 1,134.95 and a 52-week low of Rs 620.65 on 02 January, 2025 and 18 February, 2025, respectively.

Currently, the stock is trading 15.9 percent below its 52-week high and 53.78 percent above its 52-week low.

The market capitalisation of the company stands at Rs 6,393.63 crore.

Let's catch up on the latest news from the stock market. From significant investments to major deals, order wins, acquisitions, and appointments, here’s a quick look at which stocks will be in focus in today's trade:

<strong>Stocks to watch</strong>

<strong><a href="https://www.moneycontrol.com/india/stockpricequote/paintsvarnishes/akzonobelindia/ICI">Akzo Nobel India</a></strong>

Promoter Imperial Chemical Industries is likely to sell up to a 9% stake in Akzo Nobel India via a block deal, with the offer size estimated at Rs 1,290.6 crore and a floor price of Rs 3,150 per share, reports CNBC-TV18, quoting sources.

<strong><a href="https://www.moneycontrol.com/india/stockpricequote/electronics-components/kaynestechnologyindia/KTI">Kaynes Technology India</a></strong>

The company’s subsidiary, Kaynes Semicon, announced two strategic partnerships with global technology leaders—AOI Electronics Co (Japan) and Mitsui &amp; Co (Japan)—to strengthen its upcoming semiconductor manufacturing operations in India.

<strong><a href="https://www.moneycontrol.com/india/stockpricequote/constructioncontracting-civil/ahluwaliacontractsindia/ACI12">Ahluwalia Contracts (India)</a></strong>

The company has received an order worth Rs 888.38 crore from Bihar State Tourism Development Corporation. The order involves construction and overall development work of Shri Ram Janmabhoomi Tirtha Kshetra, Ayodhya, at Punauradham, Bihar, on an EPC mode.

<strong><a href="https://www.moneycontrol.com/india/stockpricequote/mediaentertainment/saregamaindia/SI67">Saregama</a></strong>

The company has executed an Investment Agreement, a Shareholders Agreement (SHA), a Music Rights Agreement (MRA), and other transaction-related documents with Bhansali Productions, acquiring 9,960 compulsory convertible preference shares (CCPS) in Bhansali Productions for Rs 325 crore.

The board also approved the terms of conversion of such CCPS and the further acquisition of additional equity securities of Bhansali Productions in multiple tranches.

The company may acquire up to a 51% stake in Bhansali Productions by March 2030.

<strong><a href="https://www.moneycontrol.com/india/stockpricequote/computers-software/hcltechnologies/HCL02">HCL Technologies</a></strong>

NSE Academy, a subsidiary of the National Stock Exchange of India, has partnered with HCLTech to deliver a series of joint certificate programs in technology and finance. These programs aim to equip students and professionals with future-ready skills for the evolving digital economy landscape in banking, insurance, financial markets, and fintech across India and the Middle East and South Asia (MESA) region.

<strong><a href="https://www.moneycontrol.com/india/stockpricequote/infrastructure-general/nbccindia/NBC01">NBCC (India)</a></strong>

The company has received an order worth Rs 332.99 crore from IIT Mandi for Project Management Consultancy services, and another order worth Rs 12.05 crore from Kandla SEZ for day-to-day annual maintenance work.

<strong><a href="https://www.moneycontrol.com/india/stockpricequote/pharmaceuticals/glenmarkpharma/GP08">Glenmark Pharmaceuticals</a></strong>

The company’s subsidiary, Glenmark Specialty S.A. (GSSA), has entered into an exclusive license, collaboration, and distribution agreement with Jiangsu Hansoh Pharmaceutical Group Co (Hansoh Pharma) for Aumolertinib, a third-generation Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor (EGFR-TKI) for the treatment of non-small cell lung cancer (NSCLC).

Hansoh Pharma will receive an upfront payment in the low double-digit million US dollars, followed by potential regulatory and commercial milestone payments possibly cumulatively exceeding $1 billion, in addition to tiered royalties on net sales in the licensed territories.

<strong><a href="https://www.moneycontrol.com/india/stockpricequote/banks-public-sector/indianoverseasbank/IOB">Indian Overseas Bank</a></strong>

The government will sell up to 38.51 crore equity shares of the bank (equivalent to 2% of the paid-up equity as the base offer size) on December 17–18, with an option to additionally sell 19.25 crore shares (1% stake), through a separate designated window of the BSE and NSE. The floor price has been fixed at Rs 34 per share.

<strong><a href="https://www.moneycontrol.com/india/stockpricequote/pharmaceuticals/sequentscientific/PID01">Sequent Scientific</a></strong>

The board has approved the appointment of Haribabu Bodepudi as Managing Director and Group Chief Executive Officer of the company for a period of two consecutive years, effective December 16. It also approved the change in designation of Rajaram Narayanan to Whole-time Director, designated as Chief Executive Officer – Animal Health, for the remaining period of his existing tenure, effective December 16.

The board also approved the appointment of Ramakant Singani as Chief Financial Officer, effective January 1, 2026, following the resignation of Saurav Bhala as CFO.

<strong><a href="https://www.moneycontrol.com/india/stockpricequote/ceramicsgranite/kajariaceramics/KC06">Kajaria Ceramics</a></strong>

Shareholders have approved the redesignation and appointment of Ashok Kajaria as Chairman, Chetan Kajaria as Vice Chairman, and Rishi Kajaria as Managing Director of the company.

<strong>Bulk Deals</strong>

<strong><a href="https://www.moneycontrol.com/india/stockpricequote/auto-ancillaries-brakes/olaelectricmobility/OEM">Ola Electric Mobility</a></strong>

Founder and promoter Bhavish Aggarwal sold 2.62 crore equity shares (equivalent to 0.59% of paid-up equity) in Ola Electric Mobility, the pure electric two-wheeler maker, for Rs 91.87 crore at Rs 34.99 per share.

Bhavish Aggarwal informed exchanges that he has undertaken a one-time, limited monetisation of a small portion of his personal stake to fully repay a promoter-level loan amounting to Rs 260 crore. “With this, all of the previously pledged 3.93% shares will be released, removing a critical overhang,” he said.

<strong><a href="https://www.moneycontrol.com/india/stockpricequote/textiles-readymade-apparels/pearlglobalindustries/HPF01">Pearl Global Industries</a></strong>

SBI Mutual Fund has acquired 6.6 lakh shares (1.43% stake) in the cloth manufacturing company for Rs 105.68 crore at Rs 1,599.99 per share. Meanwhile, promoter Deepak Kumar Seth sold 6.25 lakh shares (1.35% stake) for Rs 100 crore at Rs 1,600.04 per share.

<strong><a href="https://www.moneycontrol.com/india/stockpricequote/banks-private-sector/karnatakabank/KB04">Karnataka Bank</a></strong>

Non-institutional investor B Sumanthkumar Reddy bought 19.09 lakh shares (0.5% stake) in Karnataka Bank for Rs 38.29 crore at Rs 200.52 per share. Meanwhile, Gardens R R sold the same number of shares for Rs 38.28 crore at Rs 200.48 per share.

<strong>Block Deals</strong>

<strong><a href="https://www.moneycontrol.com/india/stockpricequote/finance-others/sbfcfinance/SF33">SBFC Finance</a></strong>

US-based Massachusetts Institute of Technology – FDI exited SBFC Finance, the non-banking finance company, by selling all 1.36 crore equity shares (equivalent to 1.25% of paid-up equity) for Rs 143.37 crore at Rs 105.14 per share.

Massachusetts Institute of Technology Basic Retirement Plan Trust also sold 13.86 lakh shares (0.12% stake) for Rs 14.57 crore, and 238 Plan Associates LLC sold 3.41 lakh shares (0.03% stake) for Rs 3.59 crore at the same price.

However, Tata AIA Life Insurance acquired 82.31 lakh shares (0.75% stake) for Rs 86.54 crore, and Aranda Investments (owned by global investor Temasek Holdings) picked up 71.33 lakh shares (0.65% stake) for Rs 75 crore at the same price.

<strong>Mainboard Listing</strong>

Nephrocare Health Services
Park Medi World

<strong>SME Listing</strong>

Unisem Agritech
Shipwaves Online

<strong>Stock Trades Ex-Date for Buyback</strong>

eClerx Services

<strong>Stock Trades Ex-Date for Rights</strong>

Krishival Foods

<strong>Stock Trades Ex-Date for Bonus</strong>

Sylph Technologies

<strong>Stock in F&amp;O ban</strong>

Bandhan Bank

Stocks to Watch Today: HCLTech, Akzo Nobel, Kaynes Tech, Ahluwalia Contracts, Saregama, NBCC, IOB, Ola Electric, Nephrocare, Park Hospitals in focus on 17 December

Let's catch up on the latest news from the stock market. From significant investments to major deals, order wins, acquisitions, and appointments, here’s a quick look at which stocks will be in focus in today's trade:

Stocks to watch

Akzo Nobel India

Promoter Imperial Chemical Industries is likely to sell up to a 9% stake in Akzo Nobel India via a block deal, with the offer size estimated at Rs 1,290.6 crore and a floor price of Rs 3,150 per share, reports CNBC-TV18, quoting sources.

Kaynes Technology India

The company’s subsidiary, Kaynes Semicon, announced two strategic partnerships with global technology leaders—AOI Electronics Co (Japan) and Mitsui &amp;amp; Co (Japan)—to strengthen its upcoming semiconductor manufacturing operations in India.

Ahluwalia Contracts (India)

The company has received an order worth Rs 888.38 crore from Bihar State Tourism Development Corporation. The order involves construction and overall development work of Shri Ram Janmabhoomi Tirtha Kshetra, Ayodhya, at Punauradham, Bihar, on an EPC mode.

Saregama

The company has executed an Investment Agreement, a Shareholders Agreement (SHA), a Music Rights Agreement (MRA), and other transaction-related documents with Bhansali Productions, acquiring 9,960 compulsory convertible preference shares (CCPS) in Bhansali Productions for Rs 325 crore.

The board also approved the terms of conversion of such CCPS and the further acquisition of additional equity securities of Bhansali Productions in multiple tranches.

The company may acquire up to a 51% stake in Bhansali Productions by March 2030.

HCL Technologies

NSE Academy, a subsidiary of the National Stock Exchange of India, has partnered with HCLTech to deliver a series of joint certificate programs in technology and finance. These programs aim to equip students and professionals with future-ready skills for the evolving digital economy landscape in banking, insurance, financial markets, and fintech across India and the Middle East and South Asia (MESA) region.

NBCC (India)

The company has received an order worth Rs 332.99 crore from IIT Mandi for Project Management Consultancy services, and another order worth Rs 12.05 crore from Kandla SEZ for day-to-day annual maintenance work.

Glenmark Pharmaceuticals

The company’s subsidiary, Glenmark Specialty S.A. (GSSA), has entered into an exclusive license, collaboration, and distribution agreement with Jiangsu Hansoh Pharmaceutical Group Co (Hansoh Pharma) for Aumolertinib, a third-generation Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor (EGFR-TKI) for the treatment of non-small cell lung cancer (NSCLC).

Hansoh Pharma will receive an upfront payment in the low double-digit million US dollars, followed by potential regulatory and commercial milestone payments possibly cumulatively exceeding $1 billion, in addition to tiered royalties on net sales in the licensed territories.

Indian Overseas Bank

The government will sell up to 38.51 crore equity shares of the bank (equivalent to 2% of the paid-up equity as the base offer size) on December 17–18, with an option to additionally sell 19.25 crore shares (1% stake), through a separate designated window of the BSE and NSE. The floor price has been fixed at Rs 34 per share.

Sequent Scientific

The board has approved the appointment of Haribabu Bodepudi as Managing Director and Group Chief Executive Officer of the company for a period of two consecutive years, effective December 16. It also approved the change in designation of Rajaram Narayanan to Whole-time Director, designated as Chief Executive Officer – Animal Health, for the remaining period of his existing tenure, effective December 16.

The board also approved the appointment of Ramakant Singani as Chief Financial Officer, effective January 1, 2026, following the resignation of Saurav Bhala as CFO.

Kajaria Ceramics

Shareholders have approved the redesignation and appointment of Ashok Kajaria as Chairman, Chetan Kajaria as Vice Chairman, and Rishi Kajaria as Managing Director of the company.

Bulk Deals

Ola Electric Mobility

Founder and promoter Bhavish Aggarwal sold 2.62 crore equity shares (equivalent to 0.59% of paid-up equity) in Ola Electric Mobility, the pure electric two-wheeler maker, for Rs 91.87 crore at Rs 34.99 per share.

Bhavish Aggarwal informed exchanges that he has undertaken a one-time, limited monetisation of a small portion of his personal stake to fully repay a promoter-level loan amounting to Rs 260 crore. “With this, all of the previously pledged 3.93% shares will be released, removing a critical overhang,” he said.

Pearl Global Industries

SBI Mutual Fund has acquired 6.6 lakh shares (1.43% stake) in the cloth manufacturing company for Rs 105.68 crore at Rs 1,599.99 per share. Meanwhile, promoter Deepak Kumar Seth sold 6.25 lakh shares (1.35% stake) for Rs 100 crore at Rs 1,600.04 per share.

Karnataka Bank

Non-institutional investor B Sumanthkumar Reddy bought 19.09 lakh shares (0.5% stake) in Karnataka Bank for Rs 38.29 crore at Rs 200.52 per share. Meanwhile, Gardens R R sold the same number of shares for Rs 38.28 crore at Rs 200.48 per share.

Block Deals

SBFC Finance

US-based Massachusetts Institute of Technology – FDI exited SBFC Finance, the non-banking finance company, by selling all 1.36 crore equity shares (equivalent to 1.25% of paid-up equity) for Rs 143.37 crore at Rs 105.14 per share.

Massachusetts Institute of Technology Basic Retirement Plan Trust also sold 13.86 lakh shares (0.12% stake) for Rs 14.57 crore, and 238 Plan Associates LLC sold 3.41 lakh shares (0.03% stake) for Rs 3.59 crore at the same price.

However, Tata AIA Life Insurance acquired 82.31 lakh shares (0.75% stake) for Rs 86.54 crore, and Aranda Investments (owned by global investor Temasek Holdings) picked up 71.33 lakh shares (0.65% stake) for Rs 75 crore at the same price.

Mainboard Listing

Nephrocare Health Services
Park Medi World

SME Listing

Unisem Agritech
Shipwaves Online

Stock Trades Ex-Date for Buyback

eClerx Services

Stock Trades Ex-Date for Rights

Krishival Foods

Stock Trades Ex-Date for Bonus

Sylph Technologies

Stock in F&amp;amp;O ban

Bandhan Bank

US-based Massachusetts Institute of Technology exited SBFC Finance, the non-banking finance company, while promoter and founder Bhavish Aggarwal has offloaded nearly 0.6 percent shares via open market transactions on December 16.

Massachusetts Institute of Technology - FDI sold all 1.36 crore equity shares (equivalent to 1.25 percent of paid-up equity) in <a href="https://www.moneycontrol.com/india/stockpricequote/finance-others/sbfcfinance/SF33" target="_blank">SBFC Finance</a> for Rs 143.37 crore at Rs 105.14 per share.

Massachusetts Institute of Technology Basic Retirement Plan Trust also sold 13.86 lakh shares (0.12 percent stake) for Rs 14.57 crore, and 238 Plan Associates LLC 3.41 lakh shares (0.03 percent stake) for Rs 3.59 crore at same price.

Both selling shareholders are part of Massachusetts Institute of Technology and their shareholding information is not available may be due to their holding below 1 percent.

However, Tata AIA Life Insurance Company, and Aranda Investments (owned by global investor Temasek Holdings) were buyers for some of the shares sold by Massachusetts Institute of Technology.

Tata AIA Life Insurance has acquired 82.31 lakh shares (0.75 percent stake) for Rs 86.54 crore, and Aranda Investments picked up 71.33 lakh shares (0.65 percent stake) for Rs 75 crore at same price.

SBFC Finance shares corrected 0.12 percent to closed at Rs 105.01 on the NSE.

Meanwhile, founder and promoter Bhavish Aggarwal sold 2.62 crore equity shares (equivalent to 0.59 percent of paid-up equity) in <a href="https://www.moneycontrol.com/india/stockpricequote/auto-ancillaries-brakes/olaelectricmobility/OEM" target="_blank">Ola Electric Mobility</a>, the pure electric two-wheeler maker, for Rs 91.87 crore at Rs 34.99 per share.

Perhaps, Ola Electric Mobility shares seem to have reacted sharply to the stake sale by promoter, declining 7.76 percent - the biggest single-day fall since August 21 - to close at Rs 34.48.

Overall, the stock has been under pressure since August 20, 2024 when it touched a record high of Rs 157.40, from which it corrected 78 percent despite intermittent buying interest. It has significantly eroded wealth of investors, having a market capitalisation of Rs 15,217 crore, against more than Rs 69,000 crore valuation recorded at the highest price.

After stake sale, Bhavish Aggarwal informed exchanges that he has undertaken a one-time, limited monetisation of a small portion of his personal stake to fully repay a promoter level loan amounting to Rs 260 crore.

"With this, all of the previously pledged 3.93 percent shares will be released, removing a critical overhang," he said.

Post the transaction, the promoter group would continue to hold approximately 34 percent in Ola Electric. There is no dilution of promoter control or change in the long-term conviction, the promoter said.

The transaction is being executed entirely at the promoter’s personal level and would have no impact on Ola Electric’s operations, governance, or strategic direction, he added.

The brief action was also seen in <a href="https://www.moneycontrol.com/india/stockpricequote/textiles-readymade-apparels/pearlglobalindustries/HPF01" target="_blank">Pearl Global Industries</a>, the cloth manufacturing company, which shares closed at Rs 1,635, down 0.07 percent. SBI Mutual Fund has acquired 6.6 lakh shares (1.43 percent stake) in the company for Rs 105.68 crore at Rs 1,599.99 per share, however, promoter Deepak Kumar Seth sold 6.25 lakh shares (1.35 percent stake) for Rs 100 crore at Rs 1,600.04 per share.

Non-institutional investor B Sumanthkumar Reddy has bought 19.09 lakh sharess (0.5 percent stake) in <a href="https://www.moneycontrol.com/india/stockpricequote/banks-private-sector/karnatakabank/KB04" target="_blank">Karnataka Bank</a> for Rs 38.29 crore at Rs 200.52 per share, however, Gardens R R sold same number of shares for Rs 38.28 crore at a price of Rs 200.48 per share. Karnataka Bank shares closed at Rs 198.42, down 0.79 percent.

Gallantt Industry has acquired 12.07 lakh shares in <a href="https://www.moneycontrol.com/india/stockpricequote/steel-sponge-iron/gallanttispat/GI" target="_blank">Gallantt Ispat</a> for Rs 71.2 crore at Rs 590 per share, from Krone Finstock.

Massachusetts Institute of Technology exits SBFC Finance, SBI MF picks up 1.4% stake in Pearl Global

US-based Massachusetts Institute of Technology exited SBFC Finance, the non-banking finance company, while promoter and founder Bhavish Aggarwal has offloaded nearly 0.6 percent shares via open market transactions on December 16.

Massachusetts Institute of Technology - FDI sold all 1.36 crore equity shares (equivalent to 1.25 percent of paid-up equity) in SBFC Finance for Rs 143.37 crore at Rs 105.14 per share.

Massachusetts Institute of Technology Basic Retirement Plan Trust also sold 13.86 lakh shares (0.12 percent stake) for Rs 14.57 crore, and 238 Plan Associates LLC 3.41 lakh shares (0.03 percent stake) for Rs 3.59 crore at same price.

Both selling shareholders are part of Massachusetts Institute of Technology and their shareholding information is not available may be due to their holding below 1 percent.

However, Tata AIA Life Insurance Company, and Aranda Investments (owned by global investor Temasek Holdings) were buyers for some of the shares sold by Massachusetts Institute of Technology.

Tata AIA Life Insurance has acquired 82.31 lakh shares (0.75 percent stake) for Rs 86.54 crore, and Aranda Investments picked up 71.33 lakh shares (0.65 percent stake) for Rs 75 crore at same price.

SBFC Finance shares corrected 0.12 percent to closed at Rs 105.01 on the NSE.

Meanwhile, founder and promoter Bhavish Aggarwal sold 2.62 crore equity shares (equivalent to 0.59 percent of paid-up equity) in Ola Electric Mobility, the pure electric two-wheeler maker, for Rs 91.87 crore at Rs 34.99 per share.

Perhaps, Ola Electric Mobility shares seem to have reacted sharply to the stake sale by promoter, declining 7.76 percent - the biggest single-day fall since August 21 - to close at Rs 34.48.

Overall, the stock has been under pressure since August 20, 2024 when it touched a record high of Rs 157.40, from which it corrected 78 percent despite intermittent buying interest. It has significantly eroded wealth of investors, having a market capitalisation of Rs 15,217 crore, against more than Rs 69,000 crore valuation recorded at the highest price.

After stake sale, Bhavish Aggarwal informed exchanges that he has undertaken a one-time, limited monetisation of a small portion of his personal stake to fully repay a promoter level loan amounting to Rs 260 crore.

&quot;With this, all of the previously pledged 3.93 percent shares will be released, removing a critical overhang,&quot; he said.

Post the transaction, the promoter group would continue to hold approximately 34 percent in Ola Electric. There is no dilution of promoter control or change in the long-term conviction, the promoter said.

The transaction is being executed entirely at the promoter’s personal level and would have no impact on Ola Electric’s operations, governance, or strategic direction, he added.

The brief action was also seen in Pearl Global Industries, the cloth manufacturing company, which shares closed at Rs 1,635, down 0.07 percent. SBI Mutual Fund has acquired 6.6 lakh shares (1.43 percent stake) in the company for Rs 105.68 crore at Rs 1,599.99 per share, however, promoter Deepak Kumar Seth sold 6.25 lakh shares (1.35 percent stake) for Rs 100 crore at Rs 1,600.04 per share.

Non-institutional investor B Sumanthkumar Reddy has bought 19.09 lakh sharess (0.5 percent stake) in Karnataka Bank for Rs 38.29 crore at Rs 200.52 per share, however, Gardens R R sold same number of shares for Rs 38.28 crore at a price of Rs 200.48 per share. Karnataka Bank shares closed at Rs 198.42, down 0.79 percent.

Gallantt Industry has acquired 12.07 lakh shares in Gallantt Ispat for Rs 71.2 crore at Rs 590 per share, from Krone Finstock.

Auto Ancillaries - Sheet Metals Industry Stocks
Check latest stock performance, list of stocks, earnings review & more details about the Auto Ancillaries - Sheet Metals industry stocks.

Gainers/Losers

Industry Market Map

Earnings Review-Q2 FY25-26

Stock News

Park Medi World shares make weak market debut, list at 4% discount to IPO price on BSE

Nephrocare Health Services shares list at 7% premium to IPO price

Ahluwalia Contracts shares gain 5% on order win worth Rs 888 crore

Stocks to Watch Today: HCLTech, Akzo Nobel, Kaynes Tech, Ahluwalia Contracts, Saregama, NBCC, IOB, Ola Electric, Nephrocare, Park Hospitals in focus on 17 December

Massachusetts Institute of Technology exits SBFC Finance, SBI MF picks up 1.4% stake in Pearl Global

Auto Ancillaries - Sheet Metals Industry StocksCheck latest stock performance, list of stocks, earnings review & more details about the Auto Ancillaries - Sheet Metals industry stocks.

Gainers/Losers

Industry Market Map

Earnings Review-Q2 FY25-26

Stock News

Park Medi World shares make weak market debut, list at 4% discount to IPO price on BSE

Nephrocare Health Services shares list at 7% premium to IPO price

Ahluwalia Contracts shares gain 5% on order win worth Rs 888 crore

Stocks to Watch Today: HCLTech, Akzo Nobel, Kaynes Tech, Ahluwalia Contracts, Saregama, NBCC, IOB, Ola Electric, Nephrocare, Park Hospitals in focus on 17 December

Massachusetts Institute of Technology exits SBFC Finance, SBI MF picks up 1.4% stake in Pearl Global

Auto Ancillaries - Sheet Metals Industry Stocks
Check latest stock performance, list of stocks, earnings review & more details about the Auto Ancillaries - Sheet Metals industry stocks.